Clinical Trial Update: Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating nano drug interventional therapy using digital subtraction angiography for lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED